Answer Addiction

Tag: cbd alternative medicine

  • Kim Kardashian West Ditches Xanax, Ambien For CBD To Help Her Sleep

    Kim Kardashian West Ditches Xanax, Ambien For CBD To Help Her Sleep

    It’s the only way the mogul can wind down and sleep through the stress.

    Kim Kardashian West is a busy person. Between Keeping Up With the Kardashians, managing several businesses, raising four kids with musician Kanye West, and even meeting with Trump to speak on behalf of non-violent drug offenders, some may wonder how she handles all the stress.

    “How do I do it all? It is exhausting. I just say CBD. [laughs] But I do. I really that has gotten me through a lot,” Kardashian, 38, told People.

    CBD, or cannabidiol, is a chemical compound extracted from the same marijuana plants that many people smoke, eat, and vape to get high. However, CBD products lack the ingredient in marijuana that gets people high, THC (tetrahydrocannabinol), which CBD users, including Kardashian, actually don’t want to consume.

    “That’s not my thing. I got into CBD a few months ago. It’s saved my life. Even to sleep at night. I like the gummies,” confessed Kardashian. “I will just use a little bit and fall asleep [laughs].”

    In fact, she’s ditched some traditional stress management and sleep aid medications in favor of the stuff. “I don’t think I would take a Xanax or an Ambien again,” she proclaimed.

    The Rise Of CBD

    CBD has gained steam as of late, with many claiming that not only can it relax people’s weary minds, it can also help suppress cravings for people in addiction recovery. Even CVS is planning to carry CBD products in 800 locations.

    It would have been easy for Kardashian to stand by and reap the benefits of public, and government, opinion turning towards the legalization of marijuana and its extracts, but she did not. Kardashian has personally fought for the freedom of not one, but two low-level drug offenders.

    In June 2018, she personally met with Trump to commute the sentence of Alice Marie Johnson, who served time for passing messages on the phone to help drug suppliers and dealers communicate. Even Kardashian was surprised by the magnitude of her own success.

    “I spoke to the president… He let me know what was going to happen [with Johnson] and he was going to sign the papers right then and there and she could be released that day,” she recounted. “I didn’t know, does that happen right away? Is there a process? What is it? So he was going to let her go. He told me she can leave today.”

    She did it again for Jeffrey Stringer in May this year as a part of her vow to affect greater change in U.S. drug policy.

    “It started with Ms. Alice, but looking at her and seeing the faces and learning the stories of the men and women I’ve met inside prisons I knew I couldn’t stop at just one,” West wrote on a Twitter. “It’s time for REAL systemic change.”

    View the original article at thefix.com

  • FDA Issues Consumer Warning On CBD Products

    FDA Issues Consumer Warning On CBD Products

    The FDA is working to research the safety of CBD and other cannabis products to better understand how to regulate them.

    The Food and Drug Administration has issued a consumer warning urging people to proceed with caution when using CBD products for themselves or their animals. 

    “The U.S. Food and Drug Administration (FDA) recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD,” the warning reads. “However, there are many unanswered questions about the science, safety, and quality of products containing CBD.”

    The FDA has only approved one CBD product, the anti-seizure medication Epidiolex. Despite that, many other products make health claims as they relate to people and animals, but the FDA cautions consumers that these claims are unsubstantiated. 

    More Research Is Needed

    “The FDA has not approved any other CBD products, and there is very limited available information about CBD, including about its effects on the body,” the warning said. 

    The FDA is working to research the safety of CBD and other cannabis products to better understand how to regulate them. This includes looking at the way that CBD affects the liver. Research has indicated that CBD can be linked with liver damage, which is cause for concern as people use the product liberally. 

    More importantly, the FDA points out that people should not use CBD products as a replacement for medical care. 

    “Misleading and false claims associated with CBD products may lead consumers to put off getting important medical care, such as proper diagnosis, treatment, and supportive care,” the warning read. “For that reason, it’s important to talk to your doctor about the best way to treat diseases or conditions with existing, approved treatment options.”

    Protecting Public Health

    The agency has issued warnings to companies that market their CBD products as ways to relieve the effects of certain diseases. 

    “The FDA’s top priority is to protect the public health, and that includes making sure consumers know about products that put their health and safety at greatest risk, such as those claiming to prevent, diagnose, treat, or cure serious diseases,” the organization wrote. 

    In addition to better understanding how CBD affects people, the FDA is researching how CBD affects animals, and whether it is safe for animal use. Right now there are many CBD products marketing for animals, but the claims for their effects are unproven, the organization said. 

    The organization is collecting public comments online through July 16. The public input will help inform policy going forward. 

    “The FDA continues to believe the drug approval process represents the best way to help ensure that safe and effective new medicines, including any drugs derived from cannabis, are available to patients in need of appropriate medical therapy,” the organization wrote. “The Agency is committed to supporting the development of new drugs, including cannabis and cannabis-derived drugs, through the investigational new drug and drug approval process.”

    View the original article at thefix.com